Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Comments on CRISPR Patent Decision

February 15, 2017  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Editas breathes sigh of relief as CRISPR ruling handed down,” an article published in MedCity News.

Read the full article here

 

Related Links

Practice Areas

Industries

News & Insights

News
Mar 2025
Knobbe Martens, Partners Named Among Finalists for Inaugural Life Sciences Patent Network Awards
IRVINE, Calif., March 4, 2025 – Knobbe Martens is proud to announce that the firm and two partners have been named finalists in multiple categories at the inaugural Life Sciences...
Publications
Mar 2025
David Schmidt and Zachary Grinovich Author World IP Review Article on NPE Litigation at the UPC
In the article “Non-practicing Entity Litigation at the UPC: A US Perspective,” lawyers David Schmidt, PhD and Zachary Grinovich explore recent developments at the Unified Patent Court that could impact...
Publications
Jan 2025
Philip Nelson Previews Upcoming Year of Key Patent Legislation in IP Watchdog Article
In the article “Legislative Developments in Patents: Prospects for the PREVAIL and RESTORE Acts and PERA in 2025,” published by IP Watchdog, partner Philip Nelson discusses three significant bills that...